follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Actavis gets FDA approval for new generic

By

Back to Top Comments Email Print

Latest News

advertisement

Actavis Inc. said today it has received Food and Drug Administration approval of its abbreviated new drug application for its treatment for opioid dependence. The drug is the generic equivalent of Reckitt Benckiser's Suboxone.

Actavis, which has its headquarters in Parsippany, said it intends to begin shipment of the product immediately. For the 12 months ending Dec. 31, Suboxone tablets had total U.S. sales of approximately $625 million, according to an announcement by Actavis.

 

 

 

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top